Description
This track shows the map of -log10(P-value) of binding sites (as determined
in the Methods below) for ChIP-chip using DNA from immunoprecipitated
chromatin from either human
HelaS3 (cervix epithelial adenocarcinoma), GM06990
(lymphoblastoid) or
K562 (myeloid leukemia-derived) cells hybridized to
maskless photolithographic arrays. The arrays consist of 50-mer
oligonucleotides tiled with 12-nt overlaps covering most of the
non-repetitive DNA sequence of the ENCODE regions. Chromatin
immunoprecipitation was carried out for each experiment using antibodies
against the following targets: BAF155, BAF170, INI1/BAF47, c-Fos, c-Jun,
TAF1/TAFII250, RNA polymerase II, histone H4 tetra-acetylated lysine
(H4Kac4), histone H3 tri-methylated lysine (H3K27me3), STAT1, nuclear factor
kappa B (NFKB) p65, SMARCA4/BRG1, SMARCA6 and NRSF. Additionally, HeLa S3 cells
immunoprecipitated with STAT1 were pre-treated with interferon-alpha and
HeLa S3 cells immunoprecipitated with NFKB antibody were pre-treated with
tumor necrosis factor-alpha (TNF-alpha) (see table below).
This track shows the combined results of three or four multiple biological
replicates. For all arrays, the ChIP DNA was labeled with Cy5 and the
control DNA was labeled with Cy3.
These data are available at NCBI GEO (see table below for links), which also provides
additional information about the experimental protocols.
Target |
GEO Accession(s) |
Description |
BAF155 (H-76) |
GSE3549 (HeLa S3 cells) and
GSE6898 (K562 cells) |
BAF155 (Brg1-Associated Factor, 155 kD) is a human homolog of yeast
SWI3. The Swi-Snf chromatin-remodeling complex was first described in yeast,
and similar proteins have been found in mammalian cells. The human Swi-Snf
complex is comprised of at least nine polypeptides, including two ATPase
subunits, Brm and Brg-1. Other members of the human Swi-Snf complex are
termed BAFs for Brg1-associated factors. BAF155 is a conserved
(core) component that stimulates the chromatin remodeling activity of
Brg1.
|
BAF170 (H-116) |
GSE3550 (HeLa S3 cells) and
GSE6896 (K562 cells) |
BAF170 (Brg1-Associated Factor, 170 kD) is a human homolog of yeast
SWI3, a protein important in chromatin remodeling. It is a conserved (core)
component of the Swi-Snf complex that stimulates the chromatin remodeling
activity of Brg1 (see the description for BAF155). |
INI1/BAF47 (H-300) |
GSE6897 (K562 cells) |
INI1 (Integrase Interactor 1) or BAF47 is a human homolog of yeast
SNF5, a protein important in chromatin remodeling. |
c-Fos |
GSE3449 (HeLa S3 cells) |
c-Fos (transcription factor) is the cellular homolog of the v-fos
viral oncogene. It is a member of the leucine zipper protein family and its
transcriptional activity has been implicated in cell growth, differentiation,
and development. Fos is induced by many stimuli, ranging from mitogens to
pharmacological agents. c-Fos has been shown to be associated with another
proto-oncogene, c-Jun, and together they bind to the AP-1 binding site to
regulate gene transcription. Like CREB, c-Fos is regulated by p90Rsk. |
c-Jun |
GSE3448 (HeLa S3 cells) |
c-Jun (transcription factor), also known as AP-1 (activator protein 1),
is the cellular homolog of the avian sarcoma virus oncogene v-jun, and as
such can be referred to as a proto-oncogene. |
TAF1/TAFII250 |
GSE3450 (HeLa S3 cells) |
TAF1 (TATA box binding protein (TBP)-associated factor, with molecular
weight 250 kD, also known as TAFII250) is involved in the
initiation of transcription by RNA polymerase II. It has histone
acetyltransferase activity, which can relieve the binding between DNA and
histones in the nucleosome. It is the largest subunit of the basal
transcription factor, TFIID. |
RNA polymerase II (N-20), N-terminus |
GSE6390 (HeLa S3 cells) and
GSE6392 (GM06990 cells) |
RNA polymerase II (pol II) catalyzes transcription of DNA for the
production of mRNAs and most snoRNAs. |
RNA polymerase II (8WG16), C-terminus |
GSE6391 (HeLa S3 cells) and
GSE6394 (GM06990 cells) |
RNA polymerase II (pol II) catalyzes transcription of DNA for the
production of mRNAs and most snoRNAs. This antibody targets the pre-initiation
complex form recognizing the C-terminal hexapeptide repeat of the large
subunit of pol II. The initiation-complex form of RNA polymerase II is
associated with the transcription start site. |
H4Kac4 |
GSE6389 (HeLa S3 cells) and
GSE6393 (GM06990 cells) |
H4Kac4 (Histone H4 tetra-acetylated lysine) is a post-translational
modification of the histone which affects chromatin remodeling. Histone H4
is found in transcriptionally active euchromatin. |
H3K27me3 |
GSE8073 (HeLa S3 cells) |
H3K27me3 (Histone H3 tri-methylated lysine) is a post-translational
modification of the histone which affects chromatin remodeling. It is known
to be associated with heterochromatin. |
STAT1 p91 (C-24) |
GSE6892 (HeLa S3 cells, interferon-alpha stimulated) |
STAT1 (Signal Transducer and Activator of Transcription 1) responds to
many cytokines and growth factors and regulates genes important for apoptosis,
inflammation, and the immune system. |
NFKB p65, N-terminus |
GSE6900 (HeLa S3 cells, TNF-alpha stimulated) |
NFKB p65 (RelA) is the strongest transcriptional-activator among the five
members of the mammalian NF-kB/Rel family and plays an essential role in
regulating the induction of genes involved in several physiological processes,
including immune and inflammatory responses. |
NFKB p65 (C-20), C-terminus |
GSE6899 (HeLa S3 cells, TNF-alpha stimulated) |
NFKB p65 (RelA) is the strongest transcriptional-activator among the five
members of the mammalian NF-kB/Rel family and plays an essential role in
regulating the induction of genes involved in several physiological processes,
including immune and inflammatory responses. |
SMARCA4/BRG1 |
GSE7370 (HeLa S3 cells) |
SMARCA4 (BRG1) is a catalytic subunit of the SWI/SNF chromatin remodeling
complex. It is a member of the SNF2 family of chromatin remodeling ATPases. |
SMARCA6 |
GSE7371 (HeLa S3 cells) |
SMARCA6 is a SNF2-like helicase linked to cell proliferation and
DNA methylation. It is a member of the SNF2 family of chromatin remodeling
ATPases. |
NRSF |
GSE7372 (HeLa S3 cells) |
NRSF (neuron-restrictive silencer factor) represses neuron-specific
genes in non-neuronal cells. |
Display Conventions and Configuration
The subtracks within this annotation
may be configured in a variety of ways to highlight different aspects of the
displayed data. Data may be thresholded by score and/or the user can specify
the display of only the top N scoring items (default is 200) for all the
subtracks. The score for each item is indicated in grayscale, with darker
shades corresponding to higher scores. The details page for an item (displayed
after clicking on an item in the track) shows the top 20 highest scoring items
displayed in the current window.
Methods
The data from replicates were quantile-normalized and median-scaled to each
other (both Cy3 and Cy5 channels). Using a 1000 bp sliding window centered
on each oligonucleotide probe, a signal map (estimating the fold enrichment
[log2 scale] of ChIP DNA) was generated by computing the pseudomedian
signal of all log2(Cy5/Cy3) ratios (median of pairwise averages) within the
window, including replicates. Using the same procedure, a -log10(P-value)
map (measuring significance of enrichment of oligonucleotide probes in the
window) for all sliding windows was made by computing P-values using the
Wilcoxon paired signed rank test comparing fluorensent intensity between
Cy5 and Cy3 for each oligonucleotide probe (Cy5 and Cy3 signals from the
same array). A binding site was determined by thresholding oligonucleotide
positions with -log10(P-value) (>= 4), extending qualified positions
upstream and downstream 250 bp, and requiring 1000 bp space between two
sites. Top 400 sites are retained for experiments (ENCODE Oct 2005 Freeze)
and for the other datasets, sites found using 1, 5 and 10% false discovery
rates (FDR) are displayed.
Verification
ChIP-chip binding sites were verified by comparing "hit lists" generated
from combinations of different biological replicates. Only experiments that
yielded a significant overlap (greater than 50 percent) were accepted. As
an independent check (for maskless arrays), data on the microarray were
randomized with respect to position and re-scored; significantly fewer hits
(consistent with random noise) were generated this way. Sites for data
from Nov. 2006, Jan. 2007, Apr. 2007 and Jun. 2007 were determined with
false discovery rates (FDR) of 1%, 5% and 10%. The lowest FDR which includes
each "Site" is displayed on that site's details page. For the ENCODE Oct
2005 Freeze data (BAF155, BAF170, Fos, Jun and TAF1 in HeLa S3 cells), the
top 400 sites are shown.
Credits
These data were generated and analyzed by the labs of Michael Snyder, Mark
Gerstein and Sherman Weissman at Yale University.
References
Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa
D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ et al.
Unbiased mapping of transcription factor binding sites along human
chromosomes 21 and 22 points to widespread regulation of noncoding RNAs.
Cell 2004 Feb 20;116(4):499-509.
Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, Nelson
FK, Sayward F, Luscombe NM, Miller P, Gerstein M et al.
CREB binds to multiple loci on human chromosome 22.
Mol Cell Biol. 2004 May;24(9):3804-14.
Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE,
Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M et al.
Distribution of NF-kappaB-binding sites across human chromosome 22.
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12247-52.
Quackenbush J.
Microarray data normalization and transformation
Nat Genet. 2002 Dec;32(Suppl):496-501.
|
|